Cellectar Biosciences (CLRB)
(Delayed Data from NSDQ)
$2.12 USD
+0.03 (1.44%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $2.11 -0.01 (-0.47%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *BMO8/13/24 |
---|---|
Current Quarter | -0.30 |
EPS Last Quarter | -0.40 |
Last EPS Surprise | 20.00% |
ABR | 1.00 |
Earnings ESP
|
23.33% |
---|---|
Current Year | -1.91 |
Next Year | -0.25 |
EPS (TTM) | -2.61 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 65.16M |
# of Estimates | NA | NA | NA | 2 |
High Estimate | NA | NA | NA | 118.42M |
Low Estimate | NA | NA | NA | 11.90M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.30 | -0.35 | -1.91 | -0.25 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.37 | -0.43 | NA | 0.45 |
High Estimate | -0.23 | -0.26 | -1.86 | 0.45 |
Low Estimate | -0.37 | -0.43 | -1.95 | -0.95 |
Year ago EPS | -0.73 | -0.82 | -3.15 | -1.91 |
Year over Year Growth Est. | 58.90% | 57.32% | 39.37% | 86.65% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 0 | 1 |
Up Last 60 Days | 1 | 1 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 1 | 1 |
Down Last 60 Days | 0 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.30 | -0.35 | -1.91 | -0.25 |
7 Days Ago | -0.30 | -0.35 | -1.90 | -0.60 |
30 Days Ago | -0.38 | -0.37 | -1.81 | -0.65 |
60 Days Ago | -0.38 | -0.37 | -1.86 | -0.67 |
90 Days Ago | -0.38 | -0.37 | -1.86 | -0.67 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.23 | -0.35 | -1.95 | -0.25 |
Zacks Consensus Estimate | -0.30 | -0.35 | -1.91 | -0.25 |
Earnings ESP | 23.33% | 0.00% | -2.36% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.40 | -0.66 | -0.82 | -0.73 | NA |
Estimate | -0.50 | -0.59 | -0.44 | -0.69 | NA |
Difference | 0.10 | -0.07 | -0.38 | -0.04 | -0.10 |
Surprise | 20.00% | -11.86% | -86.36% | -5.80% | -21.01% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more